The Chemours Company (CC)
NYSE: CC · Real-Time Price · USD
13.72
-0.57 (-3.99%)
At close: Mar 28, 2025, 4:00 PM
13.83
+0.11 (0.82%)
After-hours: Mar 28, 2025, 8:00 PM EDT
The Chemours Company Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for The Chemours Company stock have an average target of 22.89, with a low estimate of 18 and a high estimate of 28. The average target predicts an increase of 66.84% from the current stock price of 13.72.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for The Chemours Company stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
Buy | 2 | 2 | 2 | 2 | 2 | 3 |
Hold | 5 | 5 | 5 | 5 | 5 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 8 | 8 | 9 | 9 | 9 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Mizuho | Mizuho | Hold → Buy Upgrades $19 | Hold → Buy | Upgrades | $19 | +38.48% | Mar 27, 2025 |
Barclays | Barclays | Hold Maintains $23 → $19 | Hold | Maintains | $23 → $19 | +38.48% | Feb 24, 2025 |
BMO Capital | BMO Capital | Buy Maintains $34 → $27 | Buy | Maintains | $34 → $27 | +96.79% | Feb 19, 2025 |
Truist Securities | Truist Securities | Strong Buy Initiates $27 | Strong Buy | Initiates | $27 | +96.79% | Jan 28, 2025 |
Morgan Stanley | Morgan Stanley | Hold Maintains $25 → $22 | Hold | Maintains | $25 → $22 | +60.35% | Jan 13, 2025 |
Financial Forecast
Revenue This Year
6.05B
from 5.78B
Increased by 4.60%
Revenue Next Year
6.32B
from 6.05B
Increased by 4.43%
EPS This Year
1.95
from 0.57
Increased by 241.80%
EPS Next Year
2.83
from 1.95
Increased by 45.51%
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 6.3B | 6.7B | 6.8B |
Avg | 6.0B | 6.3B | 6.6B |
Low | 5.6B | 5.8B | 6.1B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 9.5% | 11.0% | 8.4% |
Avg | 4.6% | 4.4% | 4.4% |
Low | -2.6% | -4.8% | -2.8% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | 2.43 | 3.53 | 3.68 |
Avg | 1.95 | 2.83 | 3.22 |
Low | 1.57 | 2.11 | 2.60 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 325.5% | 81.1% | 29.6% |
Avg | 241.8% | 45.5% | 13.7% |
Low | 175.1% | 8.1% | -8.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.